| Importance of early precautionary actions in avoiding the spread of COVID-19: Saudi Arabia as an Example TM Alshammari, AF Altebainawi, KA Alenzi Saudi Pharmaceutical Journal 28 (7), 898-902, 2020 | 133 | 2020 |
| Pharmacovigilance systems in Arab countries: overview of 22 Arab countries TM Alshammari, N Mendi, KA Alenzi, Y Alsowaida Drug safety 42 (7), 849-868, 2019 | 47 | 2019 |
| National Drug Information Center Services through Ministry of Health Hotline Calling Center (937) in Saudi Arabia YA Alomi, HA Mudaiheem, A Alsharfa, H Albassri, K Alonizi Adv Pharmacoepidemiol Drug Saf 5 (1), 1-7, 2016 | 27 | 2016 |
| National pharmacovigilance programs in Arab countries: A quantitative assessment study TM Alshammari, KA Alenzi, SI Ata Pharmacoepidemiology and drug safety 29 (9), 1001-1010, 2020 | 16 | 2020 |
| Are countries’ precautionary actions against COVID-19 effective? An assessment study of 175 countries worldwide TM Alshammari, KA Alenzi, FA Alnofal, G Fradees, AF Altebainawi Saudi Pharmaceutical Journal 29 (5), 391-409, 2021 | 14 | 2021 |
| Current situation of medication errors in Saudi Arabia: a nationwide observational study TM Alshammari, KA Alenzi, Y Alatawi, AS Almordi, AF Altebainawi Journal of Patient Safety 18 (2), e448-e453, 2022 | 13 | 2022 |
| The evaluation of adverse drug reactions in Saudi Arabia: A retrospective observational study KA Alenzi, NS Alanazi, M Almalki, FO Alatawi Saudi Pharmaceutical Journal 30 (6), 735-741, 2022 | 8 | 2022 |
| Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease MH Mosli, HY Almudaiheem, T AlAmeel, SA Bakkari, OR Alharbi, ... Saudi Journal of Gastroenterology 29 (Suppl 1), S1-S35, 2023 | 7 | 2023 |
| National Saudi Consensus statement on the management of atopic dermatitis (2021) MI Fatani, AA Al Sheikh, MA Alajlan, RS Alharithy, Y Binamer, ... Dermatology and Therapy 12 (7), 1551-1575, 2022 | 7 | 2022 |
| Health economic burden of COVID-19 in Saudi Arabia KA Alenzi, HS Al-Malky, AF Altebainawi, HQ Abushomi, FO Alatawi, ... Frontiers in Public Health 10, 927494, 2022 | 5 | 2022 |
| Hepatotoxicity induced by fluvastatin: a reversible acute cholestatic liver injury NS Alanazi, TS Alenazi, KA Alenzi The American Journal of Case Reports 22, e931418-1, 2021 | 4 | 2021 |
| Alteration of coagulation test results and vaginal bleeding associated with the use of feverfew (Tanacetum parthenium) KA Alenzi, FH Alharbi, FM Tawhari, GS Fradees Journal of Medical Cases 12 (1), 9, 2021 | 4 | 2021 |
| Estimating the potential economic impact of the Wasfaty program on costs of antidiabetic treatment: an initiative for the digital transformation of health TM Alshammari, SI Alsubait, KA Alenzi, ZS Almalki Saudi Pharmaceutical Journal 31 (6), 1029-1035, 2023 | 3 | 2023 |
| Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study LT AlMutairi, WY Alalayet, SI Ata, KA Alenzi, Y AlRuthia Vaccines 10 (6), 977, 2022 | 3 | 2022 |
| Saudi consensus statement on biologic treatment of chronic plaque psoriasis (2020) MIA Fatani, IRA Hamadah, MA Alajlan, Y Binamer, AHS Alharbi, ... Journal of Dermatological Treatment 33 (4), 1916-1930, 2022 | 2 | 2022 |
| Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy NA Azzam, A Almutairdi, HY Almudaiheem, T AlAmeel, SA Bakkari, ... Saudi Journal of Gastroenterology, 10.4103, 2023 | 1 | 2023 |
| Psoriatic arthritis: Saudi retrospective observational study of manifestations and treatments SR Alunizi, AR AlShanqeeti, KA Alenzi, IA Al-Homood Annals of Rheumatology and Autoimmunity 2 (2), 53-57, 2022 | 1 | 2022 |
| PMS23-optimizing treatment for rheumatoid arthritis in the kingdom of Saudi Arabia (OPTRA) HY Almudaiheem, O Mohamed, D Dawoud, Y Alsuwayeh, K Alenzi, ... Value in Health 21, S291, 2018 | 1 | 2018 |
| Current practices of pharmacovigilance in Middle East: a quantitative study among Arab countries TM Alshammari, NM Alqahtani, KA Alenzi PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 257-258, 2018 | 1 | 2018 |
| Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database KA Alenzi, D Alsuhaibani, B Batarfi, TM Alshammari Frontiers in Pharmacology 15, 1364110, 2024 | | 2024 |
Thamir AlshammariMedication Safety Research Chair, King Saud University, Saudi Food and在 sfda.gov.sa 的电子邮件经过验证
